FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis.
Verbeke L, Mannaerts I, Schierwagen R, Govaere O, Klein S, Vander Elst I, Windmolders P, Farre R, Wenes M, Mazzone M, Nevens F, van Grunsven LA, Trebicka J, Laleman W.
Verbeke L, et al. Among authors: trebicka j.
Sci Rep. 2016 Sep 16;6:33453. doi: 10.1038/srep33453.
Sci Rep. 2016.
PMID: 27634375
Free PMC article.